This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Applied Genetic Technologies 過去の業績
過去 基準チェック /06
主要情報
-39.8%
収益成長率
-21.1%
EPS成長率
| Biotechs 業界の成長 | 17.0% |
| 収益成長率 | -57.4% |
| 株主資本利益率 | -398.0% |
| ネット・マージン | -21,610.5% |
| 前回の決算情報 | 30 Sep 2022 |
最近の業績更新
Recent updates
AGTC receives positive feedback from FDA for manufacturing facility
Jul 26Applied Genetic Technologies proposes stock offering to fund clinical trials
Jul 12Applied Genetic Tech: A Speculative Biotech With Potential To Turn Corner In 2022
Jan 12An Assessment Of Applied Genetic Technologies Corporation
Dec 14Applied Genetic Technologies: Weak Early Clinical Ocular Results Highlight Increased Risk
Jul 15Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?
May 21
Applied Genetic trades lower after announcing the departure of chief scientific officer
Apr 26What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?
Feb 05
Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?
Jan 06What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Dec 11Interim data on gene therapy for vision loss disorder fails to lift Applied Genetic
Nov 11収支内訳
収支内訳
Applied Genetic Technologies の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 22 | 0 | -70 | 17 | 28 |
| 30 Jun 22 | 0 | -69 | 17 | 28 |
| 31 Mar 22 | 1 | -63 | 17 | 25 |
| 31 Dec 21 | 1 | -63 | 16 | 23 |
| 30 Sep 21 | 1 | -60 | 15 | 22 |
| 30 Jun 21 | 1 | -58 | 15 | 21 |
| 31 Mar 21 | 0 | -60 | 14 | 21 |
| 31 Dec 20 | 0 | -57 | 14 | 21 |
| 30 Sep 20 | 2 | -50 | 14 | 27 |
| 30 Jun 20 | 2 | -46 | 14 | 21 |
| 31 Mar 20 | 3 | -42 | 13 | 21 |
| 31 Dec 19 | 24 | -19 | 13 | 29 |
| 30 Sep 19 | 28 | -15 | 13 | 20 |
| 30 Jun 19 | 42 | -2 | 13 | 19 |
| 31 Mar 19 | 47 | 2 | 13 | 2 |
| 31 Dec 18 | 29 | -18 | 14 | 1 |
| 30 Sep 18 | 28 | -19 | 14 | 5 |
| 30 Jun 18 | 24 | -21 | 14 | 0 |
| 31 Mar 18 | 27 | -18 | 14 | 27 |
| 31 Dec 17 | 32 | -11 | 13 | 15 |
| 30 Sep 17 | 38 | -4 | 12 | 15 |
| 30 Jun 17 | 39 | 0 | 11 | 15 |
| 31 Mar 17 | 43 | 6 | 11 | 11 |
| 31 Dec 16 | 47 | 10 | 10 | 11 |
| 30 Sep 16 | 48 | 11 | 10 | 11 |
| 30 Jun 16 | 47 | -1 | 10 | 11 |
| 31 Mar 16 | 36 | -12 | 10 | 0 |
| 31 Dec 15 | 24 | -20 | 11 | 0 |
質の高い収益: AGTC is currently unprofitable.
利益率の向上: AGTC is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: AGTC is unprofitable, and losses have increased over the past 5 years at a rate of 39.8% per year.
成長の加速: Unable to compare AGTC's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: AGTC is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (60.8%).
株主資本利益率
高いROE: AGTC has a negative Return on Equity (-398.02%), as it is currently unprofitable.